Bristol’s clinical trials units awarded full registration
Two clinical trials units at the University of Bristol have been awarded full registration by the UK Clinical Research Collaboration (UKCRC).
Faculty of Health Sciences
Cell scaffolding protein fascin-1 hijacked by cancer
A protein involved in the internal cell scaffold is associated with increased risk of metastasis and mortality in a range of common cancers finds a study by University of Bristol researchers published in Biomed Central’s open access journal BMC Medicine.
Most babies slow to grow catch up by early teens
New parents are pleased when their baby gains weight as expected, but if the rate of weight gain is slow parents can become worried and concerned about their child’s future size.
Methadone reduces risk of HIV transmission in people who inject drugs, say experts
People who inject drugs (PWID) can significantly reduce their risk of HIV infection with the use of opiate substitution treatments such as methadone, as suggested by an international team of researchers in a paper published today on bmj.com.
New antiviral treatment could significantly reduce global burden of hepatitis C
Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could potentially reduce HCV rates in some cities affected by chronic HCV prevalence by half over 15 years.
Could a common blood pressure drug slow down the progression of Alzheimer’s?
A groundbreaking trial that hopes to discover if a drug commonly used to treat high blood pressure could slow down the progression of Alzheimer’s disease (AD) will begin shortly thanks to funding of nearly £2 million by the Medical Research Council (MRC) and managed by the National Institute for Health Research.
Study calls for better support for adults born with cleft lip and palate
New research has found adults need better support to enable them to cope with the challenges of being born with a cleft lip and/or palate.
Duration of breastfeeding during infancy does not reduce a child’s risk of being overweight/obese at 11.5 years
A new study that analysed the effects of an intervention which succeeded in improving the duration and exclusivity of breastfeeding during infancy - involving nearly 14,000 healthy infants in Belarus, Eastern Europe - found that it did not result in a lower risk of overweight or obesity among the children at age 11.5 years. The research, led by academics at the University of Bristol, is published in the Journal of the American Medical Association [JAMA].
The high-tech future of healthcare: a digital health assistant in your home
The UK’s healthcare system faces unprecedented challenges. A pioneering new collaboration, led by the University of Bristol, hopes to address these challenges by developing a 24/7 digital home health assistant thanks to a grant awarded by the Engineering and Physical Sciences Research Council (EPSRC) of £12 million.
Study reveals the benefits of Alexander Technique lessons for sufferers of chronic pain
Sufferers of chronic pain may benefit from learning the Alexander Technique in NHS outpatient pain clinics according to a new study. More than half of the service users in the study stopped or reduced their use of medications between the start of the lessons and three months.